Hims and Hers shares fall 10% as FTC sues company over data, billing practices
Shares of telehealth company Hims & Hers Health fell sharply Wednesday after the Federal Trade Commission sued the company, alleging...
Health care industry
Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line
Cheng Xin | Getty Images News | Getty ImagesHumana on Wednesday reported second-quarter results that topped estimates, as the health...
Kentucky Gov. Beshear calls on Mitch McConnell to prove he can serve or resign
Andy Beshear, governor of Kentucky and Senator Mitch McConnell (R-KY).KC McGinnis | Bloomberg | Nathan Posner | Anadolu | Getty...
Consolidated food supply may be worsening cyclospora outbreaks, experts say
Vegetables on display in a grocery store on August 15, 2025 in Delray Beach, Florida. Joe Raedle | Getty ImagesThe...
Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says
The increased use of weight-loss drugs has created a big opportunity for aesthetics company Galderma, its CEO told CNBC on...
RFK Jr. says cyclospora outbreak is 'under control'
Secretary of Health and Human Services Robert F. Kennedy, Jr., speaks during a press conference at the Health and Human...
What to know about testosterone replacement therapy as the U.S. military plans to test troops
US Secretary of Defense Pete Hegseth speaks during a press briefing at the Pentagon in Washington, DC, on April 8,...
UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs
UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as the company...
Outbreak of diarrhea-causing parasite grows to more than 1,000 cases
Technician holding a specimen container with stool sample for cyclospora test.Md Babul Hosen | Istock | Getty ImagesNearly 1,000 people...
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Michael Siluk | UCG | Universal Images Group | Getty ImagesLosing weight with GLP-1 drugs is only half the battle....
AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed to meet...
French biotech stock soars 34% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease,...
Medicare will start covering obesity drugs for the first time. Here's what patients should know
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity...
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news conference in...
Estrogen patches are hard to find, and it may not be resolved any time soon
Woman applying estrogen patch during hormone therapy.Halfpoint Images | Moment | Getty ImagesEstrogen patches are in short supply as demand...
SNAP restrictions could change what shoppers buy — and food giants are watching
The growing push to restrict Americans from using federal food aid to buy certain processed or sugary products is creating...
What this biotech's volatile stock price tells you about the weight loss market right now
Shares of Danish biotech Zealand Pharma recently plunged after detailed data on its weight loss drug survodutide showed far higher...
Centene to offer buyouts to some employees as health insurer cuts costs
Sheldon Cooper | Lightrocket | Getty ImagesCentene said it offered buyouts to some employees on Monday, as the health insurer...
Drugmakers race to find a place in the next wave of obesity drugs
Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even...
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare...
